Equites Radar

ATR · AptarGroup, Inc.

Medical Instruments & SuppliesUnited StatesAnalyst view: Strong Buy

$132.36

+3.33% last session

End-of-day data · updated 2026-07-28

Mildly bullish3 bullish · 2 bearish technical signals
Consensus: Buy (1.50 from 7 analysts)
To mean target: +25.0%

Market cap

$9B

Enterprise value

$10B

Trailing P/E

22.8

Forward P/E

21.3

Dividend yield

1.0%

Beta

0.38

Avg volume

1M

Employees

14K

2D change

5D change

3.39%

10D change

0.57%

30D change

5.87%

60D change

15.12%

MTD change

6.48%

YTD change

10.21%

Analyst Outlook

Consensus ratingBuy
Recommendation mean (1–5)1.50
Covering analysts7
Mean price target$165.43
Low price target$140.00
Upside to mean target+25.0%

Analyst estimates change daily — follow the shifts on the Estimate Trends page.

Technical Analysis

RSI (14)71.4
50-day MA$121.54
200-day MA$124.60
Price vs 50-day MA+13.4%
Price vs 200-day MA+10.6%
MACD histogram0.47
Volume vs 3-month avg0.9×
52w low $111.9452w high $159.15

Analyst sentiment over time — ATR

Rec Mean (blue, left — higher = more bullish) vs. price targets (right).

Investment Bank Ratings as of 2026-05-04

Latest call per bank · past 12 months

Wells Fargo

Overweight

$145

+9.5% vs price
▲ raised from $144Maintains · 2026-05-04

Recent rating actions

DateFirmActionRatingPrice target
2026-05-04Wells FargoMaintainsOverweight$144 $145
2026-03-20Wells FargoUpgradeEqual-WeightOverweight$133 $144
2026-01-06Wells FargoDowngradeOverweightEqual-Weight$133
2025-11-03Wells FargoMaintainsOverweight$152 $133
2025-11-03BairdMaintainsOutperform$160 $145
2025-09-10Wells FargoMaintainsOverweight$153 $152
2025-09-04KeybancInitiatesOverweight$0.00 $220
2025-08-04Wells FargoMaintainsOverweight$173 $153

Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.

Signal Summary as of 2026-07-28

  • RSI (14): RSI is 71 — overbought territory; the recent run-up may be due for a pause.
  • Price vs 50-day MA: Trading 13.4% above the 50-day MA ($121.54).
  • Price vs 200-day MA: Trading 10.6% above the 200-day MA ($124.60).
  • MA cross: The 50-day MA sits below the 200-day MA (death-cross regime) — the longer-term trend points down.
  • MACD (12,26,9): MACD histogram is positive (+0.47) — short-term momentum is improving.
  • 52-week range: Price sits between the 52-week low ($111.94) and high ($159.15).

ATR Price Chart

Loading chart for ATR

Fundamentals

Revenue (TTM)$4.0B
EBITDA$1.0B
Free cash flow$0M
Operating cash flow$1.0B
Book value / share$41.15
Net debt / EBITDA1.5
WACC7.0%
Revenue growth11.00%
Earnings growth-4.00%

About AptarGroup, Inc.

AptarGroup, Inc. designs and manufactures drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, fragrance, facial skincare, color cosmetics, personal care, home care, and food and beverage markets. The company operates through three segments: Pharma, Beauty, and Closures. It provides dispensing pumps used to dispense sprays, liquids, or lotions from non-pressurized containers; fine-mist pumps for pharmaceutical and fragrance applications; and lotion pumps for viscous formulations, as well as closures, such as dispensing and non-dispensing solutions that enable product delivery without removal of the cap and used across various consumer end markets. The company also offers aerosol valves used in pressurized containers and continuous spray and metered-dose valves for pharmaceutical, personal care, and household applications; elastomeric primary packaging components; active material science solutions; and digital health solutions. The company primarily sells its products and services in Asia, Europe, Latin America, and North America. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.

More in Medical Instruments & Supplies

Screen ATR against the full market on the Radar →

Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.